In the past this has lead to studies examining drug-taking behavior in these patients, since exposure is a function of both individual variability in pharmacokinetics and individual patterns of drug-taking behavior.At the present time, my interests in HIV are in the access and quality of antiretroviral drugs for patients from less developed countries.